1204 ORAL A Phase lb Open-label Study to Assess Continuous Oral Treatment With Afatinib (BIBW 2992) in Combination With Two Chemotherapy Regimens – Cisplatin Plus Paclitaxel, and Cisplatin Plus 5-fluorouracil in Patients, With Advanced Solid Tumours
J. Vermorken, S. Rottey, E. Ehrnrooth, K. Pelling, A. Lahogue, J. MachielsVolume:
47
Year:
2011
Language:
english
DOI:
10.1016/s0959-8049(11)70816-4
File:
PDF, 46 KB
english, 2011